Clinical Trial

Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 22, 2026 (before its estimated February 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
To predict prostate cancer by ultrasound radiomics in ultrasound fusion prostate targeted biopsy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-02-27.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-01-20
Trial Details
NCT Number NCT05761912
Lead Sponsor Shanghai Minhang Central Hospital
Collaborators: Wu Jieping Medical Foundation, Shanghai Municipal Commission of Health and Family Planning
Conditions Prostate Cancer, Ultrasound, Radiomics
Enrollment 464 participants
Start Date 2025-06-23
Primary Completion 2026-02-15 (estimated)
Study Completion 2026-02-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-22